Shenzhen Hepalink Pharmaceutical Group Co., Ltd. at its Annual General Meeting held on 22 May 2023 approved cash dividend of CNY 1.00000000 per 10 shares (tax included) for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 CNY | -0.43% |
|
-3.83% | -20.72% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.72% | 1.7B | |
+20.37% | 43.54B | |
+18.30% | 21.78B | |
+17.66% | 15.38B | |
+25.55% | 15.12B | |
+60.99% | 13.36B | |
-0.05% | 6.79B | |
-14.84% | 6.38B | |
-8.87% | 5.73B | |
+8.17% | 5.32B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022